March 7, 2023 12:30 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Genen­tech dou­bles down on an­ti-racism; Eli Lil­ly rolls first so­cial video on $35 or less in­sulin

Beth Snyder Bulik

Senior Editor

Genen­tech is am­pli­fy­ing its com­mit­ment — and in­creas­ing its pledges — to counter sys­temic racism in health­care and ed­u­ca­tion. The Roche com­pa­ny and its Genen­tech Foun­da­tion re­cent­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times